Katalin Kauser, M.D., Ph.D., DS.c.
Vice President, Head of Biology
Dr. Katalin Kauser joined Alucent Biomedical after 20 years of experience in the pharmaceutical industry, specializing in cardiovascular research aimed at developing innovative therapeutics for treating ischemic cardiac disease, atherosclerosis, systemic hypertension, chronic kidney disease, pulmonary hypertension, pulmonary fibrosis, heart failure, and hematologic disorders. Most recently she served as the senior vice president of biology and a member of the executive management team at Global Blood Therapeutics. Previously, Dr. Kauser has held a number of leadership positions in leading cardiovascular therapeutics companies such as Boehringer-Ingelheim Pharmaceuticals Inc., Actelion Pharmaceuticals Ltd. and Bayer HealthCare Ltd,. successfully managing multidisciplinary product development teams. Dr. Kauser is a recognized vascular biologist, especially in the field of endothelial dysfunction and endothelial nitric oxide synthase regulation, from basic physiology to regenerative medicine applications. She holds a Doctor of Medicine from Semmelweiss Medical University and a Ph.D. and D.Sc. in physiology and medical sciences from the Hungarian Academy of Science.